Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Design, synthesis and anticancer potential of new peptide conjugates via urokinase inhibition: biological and in silico studies. Local targets link to admitted publications; unresolved targets remain external evidence.
Anticancer peptide: physicochemical property, functional aspect and trend in clinical application
10.3892/ijo.2020.5099 · 2020 · External reference
Towards breast cancer targeting: synthesis of tetrahydroindolocarbazoles, antibreast cancer evaluation, uPA inhibition, molecular genetic and molecular modelling studies
10.1016/j.bioorg.2019.103332 · 2019 · External reference
Anticancer peptides mechanisms, simple and complex
10.1016/j.cbi.2022.110194 · 2022 · External reference
Urokinase-type plasminogen activator
10.1016/j.biocel.2006.10.008 · 2007 · External reference
Modulation of cellular function by the urokinase receptor signalling: a mechanistic view
10.3389/fcell.2022.818616 · 2022 · External reference
Urokinase-type plasminogen activator receptor (uPAR) in inflammation and disease: a unique inflammatory pathway activator
10.3390/biomedicines12061167 · 2024 · External reference
Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation
2021 · External reference
Therapeutic strategies targeting urokinase and its receptor in cancer
10.3390/cancers14030498 · 2022 · External reference
Enhancement of cutaneous wound healing by Dsg2 augmentation of uPAR secretion
10.1016/j.jid.2018.04.024 · 2018 · External reference
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
10.1186/s12967-022-03329-3 · 2022 · External reference
Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization
10.1016/j.biocel.2008.01.020 · 2008 · External reference
Cancer treatment using peptides: current therapies and future prospects
2012 · External reference
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
10.1186/1472-6769-6-1 · 2006 · External reference
Crystals of the urokinase type plasminogen activator variant βc-uPA in complex with small molecule inhibitors open the way towards structure-based drug design
10.1006/jmbi.2000.3966 · 2000 · External reference
Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty?
10.1002/ijc.26156 · 2011 · External reference
Systematic evaluation of structure–property relationships and pharmacokinetics in 6-(hetero) aryl-substituted matched pair analogs of amiloride and 5-(N, N-hexamethylene) amiloride
10.1016/j.bmc.2021.116116 · 2021 · External reference
A review on structure, modifications and structure-activity relation of quercetin and its derivatives
10.4014/jmb.1907.07003 · 2019 · External reference
Advancements in serine protease inhibitors: from mechanistic insights to clinical applications
10.3390/catal14110787 · 2024 · External reference
Synthesis, molecular docking and anticancer studies of peptides and iso-peptides
10.1016/j.bmcl.2015.05.020 · 2015 · External reference
Tri-, tetra-and pentapeptidoylbenzotriazoles: novel synthetic intermediates
10.1055/s-0030-1260159 · 2011 · External reference
10.1002/ejoc.201200323
10.1002/ejoc.201200323 · External reference
Unresolved reference
2009 · External reference
An efficient one-pot access to trithiocarbonate-tethered peptidomimetics
10.1016/j.tetlet.2010.09.075 · 2010 · External reference
Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability
10.1016/s0196-9781(01)00537-x · 2001 · External reference
Synthesis of chiral α-amino acid-derived 1H-1,2,4-triazoles and 1,2,4-triazines
10.1039/c1md00177a · 2012 · External reference
Manufacturing peptides as active pharmaceutical ingredients
10.4155/fmc.09.23 · 2009 · External reference
Synthesis of some anticancer agent conjugated to aminoacids through amide bond with expected biological activity
2015 · External reference
High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread
10.1016/s0014-5793(02)03311-2 · 2002 · External reference
Targeted imaging of uPAR expression in vivo with cyclic AE105 variants
10.1038/s41598-023-43934-w · 2023 · External reference
Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy
10.7150/thno.5557 · 2013 · External reference
4-amidinobenzylamine-based inhibitors of urokinase
10.1016/s0960-894x(01)00815-0 · 2002 · External reference
Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents
10.1074/jbc.m314151200 · 2004 · External reference
Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors
10.1016/s0960-894x(00)00149-9 · 2000 · External reference
Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: optimization of the P4 position
10.1021/jm060622g · 2006 · External reference
Role of anti-cancer peptides as immunomodulatory agents: potential and design strategy
10.3390/pharmaceutics14122686 · 2022 · External reference
Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)
10.2147/tcrm.2007.3.2.341 · 2007 · External reference
Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes
10.1371/journal.pone.0126172 · 2015 · External reference
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo
10.1016/j.peptides.2017.12.016 · 2018 · External reference
Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors
1983 · External reference
Different roles of carboxylic functions in pharmaceuticals and agrochemicals
2016 · External reference
Exploration of biological potency of carboxylic acid derivatives: designing, synthesis, characterizations and molecular docking study
10.1016/j.molstruc.2020.127809 · 2020 · External reference
Amino acids in cancer
10.1038/s12276-020-0375-3 · 2020 · External reference
Synthesis and antitumor evaluation of amino acid conjugates of monocarbonyl curcumin in hepatocellular carcinoma cell
10.1038/s41598-025-93451-1 · 2025 · External reference
Amino-acid-conjugated natural compounds: aims, designs and results
10.3390/molecules27217631 · 2022 · External reference
Amino acids as promoieties in prodrug design and development
10.1016/j.addr.2012.10.001 · 2013 · External reference
Preparation, diagnosis and evaluation of cyclic-tryptophan derivatives as anti breast cancer agents
10.13005/bpj/2296 · 2021 · External reference
D-Amino acid position influences the anticancer activity of galaxamide analogs: an apoptotic mechanism study
10.3390/ijms18030544 · 2017 · External reference
Indole derivatives: a versatile scaffold in modern drug discovery—an updated review on their multifaceted therapeutic applications (2020–2024)
10.3390/molecules29194770 · 2024 · External reference
A brief review of the biological potential of indole derivatives
10.1186/s43094-020-00141-y · 2020 · External reference
Recent progress of bioactivities, mechanisms of action, total synthesis, structural modifications and structure-activity relationships of indole derivatives: a review
10.2174/1389557522666220330123538 · 2022 · External reference
N-valproyl-L-phenylalanine as new potential antiepileptic drug: synthesis, characterization and in vitro studies on stability, toxicity and anticonvulsant efficacy
10.2174/1573406410666140507094954 · 2015 · External reference
A WXW motif is required for the anticancer activity of the TAT-RasGAP317–326 peptide
10.1074/jbc.m114.576272 · 2014 · External reference
Hybrids of coumarin derivatives as potent and multifunctional bioactive agents: a review
10.2174/1573406415666190416121448 · 2020 · External reference
Amino acid conjugates of 2-mercaptobenzimidazole provide better anti-inflammatory pharmacology and improved toxicity profile
10.1002/ddr.21728 · 2020 · External reference
Recent advances in steroid amino acid conjugates: old scaffolds with new dimensions
10.1016/j.ejmech.2019.111909 · 2020 · External reference
Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers
10.1021/mp900084v · 2009 · External reference
Applications of benzotriazole methodology in heterocycle ring synthesis and substituent introduction and modification
10.1002/jhet.5570350511 · 1998 · External reference
Benzotriazole: a novel synthetic auxiliary
10.1016/s0040-4020(01)87080-0 · 1991 · External reference
General and efficient carbon insertion route to one-carbon-homologated. alpha.-aryl,. alpha.-alkenyl,. alpha.-alkoxy, and. alpha.-phenylthio alkyl ketones
10.1021/ja00153a032 · 1995 · External reference
General and efficient insertions of carbons carrying aryl and heteroaryl groups: synthesis of α-aryl-and α-heteroaryl-substituted ketones
10.1021/jo960841h · 1996 · External reference
Benzotriazole as a synthetic auxiliary
10.5562/cca2124 · 2012 · External reference
Unresolved reference
2016 · External reference
Aminoacyl benzotriazolides: versatile reagents for the preparation of peptides and their mimetics and conjugates
2013 · External reference
10.1016/j.tet.2004.01.020
10.1016/j.tet.2004.01.020 · External reference
10.1016/j.tet.2005.08.031
10.1016/j.tet.2005.08.031 · External reference
The diisopropylcarbodiimide/1-hydroxy-7-azabenzotriazole system: segment coupling and stepwise peptide assembly
10.1016/s0040-4020(99)00344-0 · 1999 · External reference
Efficiency in peptide coupling: 1-hydroxy-7-azabenzotriazole vs 3, 4-dihydro-3-hydroxy-4-oxo-1, 2, 3-benzotriazine
10.1021/jo00116a054 · 1995 · External reference
Use of onium salt-based coupling reagents in peptide Synthesis1
10.1021/jo980807y · 1998 · External reference
The 5, 6-and 4, 5-benzo derivatives of 1-hydroxy-7-azabenzotriazole
10.1021/ol016063j · 2001 · External reference
A selective method for the preparation of primary amides: synthesis of Fmoc-l-4-carboxamidophenylalanine and other compounds
10.1016/s0040-4039(99)00245-2 · 1999 · External reference
Addition of HOAt dramatically improves the effectiveness of pentafluorophenyl-based coupling reagents
10.1016/s0040-4039(99)00089-1 · 1999 · External reference
PyBOP®: a new peptide coupling reagent devoid of toxic by-product
10.1016/s0040-4039(00)94371-5 · 1990 · External reference
O-Benzotriazolyl-N, N, N′, N′-tetramethyluronium hexafluorophosphate as coupling reagent for the synthesis of peptides of biological interest
10.1055/s-1984-30895 · 1984 · External reference
1-Hydroxy-7-azabenzotriazole (HOAt) and N-[(dimethylamino)-1H-1, 2, 3-triazolo-[4, 5-b] pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate N-oxide (HATU)
10.1055/s-2001-18098 · 2001 · External reference
Highly efficient synthesis of sterically hindered peptides containing N-methylated amino acid residues using a novel 1H-benzimidazolium salt
10.1016/s0040-4020(00)00963-7 · 2000 · External reference
Preparation of peptides using mixed carboxylic acid anhydrides
10.1021/ja01156a011 · 1951 · External reference
Chiral acylation with N-(protected α-aminoacyl) benzotriazoles for advantageous syntheses of peptides and peptide conjugates
10.1055/s-0029-1217827 · 2009 · External reference
Efficient conversion of carboxylic acids into N-acylbenzotriazoles
10.1055/s-2003-42462 · 2003 · External reference
EGFR inhibitors and apoptotic inducers: design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules
10.1016/j.bioorg.2019.102997 · 2019 · External reference
N-(Cbz-and Fmoc-α-aminoacyl) benzotriazoles: stable derivatives enabling peptide coupling of Tyr, Trp, Cys, Met, and Gln with free amino acids in aqueous media with complete retention of chirality
10.1055/s-2005-861782 · 2005 · External reference
Regiospecific C-acylation of pyrroles and indoles using N-acylbenzotriazoles
10.1021/jo034187z · 2003 · External reference
Unresolved reference
2002 · External reference
Acylbenzotriazoles as advantageous N-, C-, S-, and O-acylating agents
10.1055/s-2005-871551 · 2005 · External reference
An efficient greener approach for N-acylation of amines in water using benzotriazole chemistry
10.3390/molecules25112501 · 2020 · External reference
New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: synthesis, molecular modeling simulations and anticancer activity
10.1016/j.ejmech.2022.114661 · 2022 · External reference
Synthesis, antitumor, cytotoxic and antioxidant evaluation of some new pyrazolotriazines attached to antipyrine moiety
10.1016/j.ejmech.2012.08.034 · 2012 · External reference
Synthesis, mass spectroscopic studies, cytotoxicity evaluation and quantitative structure activity relationship of novel isoindolin-1, 3-dione derivatives
2014 · External reference
Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo [3, 4-b] pyridine derivatives as potential anticancer agents
10.1016/j.bioorg.2016.05.006 · 2016 · External reference
Intraperitoneal injection of a hairpin RNA–expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice
10.1158/1078-0432.ccr-06-3032 · 2007 · External reference
Anti-cancer therapies targeting the tumor stroma
10.1007/s00262-007-0365-5 · 2008 · External reference
Targeting uPA/uPAR in prostate cancer
10.1016/j.ctrv.2007.06.003 · 2007 · External reference
DNA binding studies of novel diazatruxenones analogs as potential anticancer agents: synthesis, antitumor investigation, DNA binding, SAR and molecular modeling calculation
10.1016/j.bioorg.2020.104323 · 2020 · External reference
Synthesis and structure–activity relationship studies of cytotoxic anhydrovinblastine amide derivatives
10.1021/np900157t · 2009 · External reference
Convenient synthesis of ibuprofen and naproxen aminoacyl, dipeptidoyl and ester derivatives
10.1111/j.1747-0285.2009.00811.x · 2009 · External reference
Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity
10.1016/j.bioorg.2020.103797 · 2020 · External reference
Optimization strategy of novel peptide-based Michael acceptors for the treatment of human African trypanosomiasis
10.1021/acs.jmedchem.9b00908 · 2019 · External reference
Synthesis of α-fluorocinnamate derivatives as novel cathepsin S inhibitors with in vitro antiproliferative activity against pancreatic cancer cells
10.1016/j.bmc.2024.117987 · 2024 · External reference
Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer
10.1002/med.10054 · 2004 · External reference
Flexible alignment of small molecules
10.1021/jm0002634 · 2001 · External reference
Structural characteristics of antifolate dihydrofolate reductase enzyme interactions
10.1080/08893110701337727 · 2006 · External reference
Multiple conformers in active site of human dihydrofolate reductase F31R/Q35E double mutant suggest structural basis for methotrexate resistance
10.1074/jbc.m109.018010 · 2009 · External reference
Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms
10.1021/ja00467a001 · 1977 · External reference
Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases
10.1080/07391102.2020.1824814 · 2022 · External reference
Molecular dynamics simulations of the interactions between glial cell line-derived neurotrophic factor family receptor GFRα1 and small-molecule ligands
10.1021/acsomega.8b01524 · 2018 · External reference
